Abstract:Graphene family nanomaterials (GFNs) have attracted significant attention due to their unique characteristics and applications in the fields of biomedicine and nanotechnology. However, previous studies highlighted the in vitro and in vivo toxicity of GFNs with size and oxidation state differences are still elusive. Therefore, we prepared graphene (G) and graphene oxide (GO) of three different sizes (S-small, M-medium, and L-large), and characterized them using multiple surface-sensitive analytical techniques. In vitro assays using HEK 293T cells revealed that the small and large sizes of G and GO significantly reduced the cell viability and increased DNA damage, accompanying with activated reactive oxygen species (ROS) generation and induced various expressions of associated critical genetic markers. Moreover, the bacterial assays highlighted that G and GO caused strong acute toxicity on Tox2 bacteria. Effects of G were higher than GO and showed size dependent effect: L > M > S, while the medium size of GO induced mild genetic toxicity on RecA bacteria. In vivo assays revealed that exposure to G and GO caused the developmental toxicity, induced ROS generation, and activated related pathways (specifically GO) in zebrafish. Taken together, G showed stronger ability to decrease the survival rate and induce the acute toxicity, while GO showed obvious toxicity in terms of DNA damages, ROS generation, and abnormal gene expressions. Our findings highlighted that G and GO differentially induced toxicity based on their varying physical characteristics, especially sizes and oxidation state, and exposure concentrations and sensitivity of the employed in vitro and in vivo models. In short, this study provided deep insights on the negative effects of GFNs exposure.

Effects of Graphene Oxide on the Structure of Human Γ-Globulins

Effect of graphene oxide on conformation and activity of catalase

Biological applications of graphene oxide

In Vitro Toxicity Evaluation of Graphene Oxide on A549 Cells.

Cytotoxicity of Graphene: Recent Advances and Future Perspective.

Protein Corona-Mediated Mitigation of Cytotoxicity of Graphene Oxide.

Localization-delocalization matrices and electron density-weighted adjacency matrices: new electronic fingerprinting tools for medicinal computational chemistry.

Dependence of Graphene Oxide (GO) Toxicity on Oxidation Level, Elemental Composition, and Size

Biocompatibility of graphene oxide intravenously administrated in mice—effects of dose, size and exposure protocols

Comparisons Between Graphene Oxide and Graphdiyne Oxide in Physicochemistry Biology and Cytotoxicity

Effect of Size and Dose on the Biodistribution of Graphene Oxide in Mice.

Role of surface charge and oxidative stress in cytotoxicity and genotoxicity of graphene oxide towards human lung fibroblast cells.

Graphene Oxide Can Induce in Vitro and in Vivo Mutagenesis.

Toxicity of Graphene Oxide and Multi-Walled Carbon Nanotubes Against Human Cells and Zebrafish

Comprehensive Assessment of Graphene Oxide Nanoparticles: Effects on Liver Enzymes and Cardiovascular System in Animal Models and Skeletal Muscle Cells

Coagulation Behavior of Graphene Oxide on Nanocrystallined Mg/Al Layered Double Hydroxides: Batch Experimental and Theoretical Calculation Study

Drying of graphene oxide: effects on red blood cells and protein corona formation

Nanotoxicity of different sizes of graphene (G) and graphene oxide (GO) in vitro and in vivo.

Evaluation of the Antibacterial, Anti-Cervical Cancer Capacity, and Biocompatibility of Different Graphene Oxides

Graphene oxide and bacteria interactions: what is known and what should we expect?

Toxicology Data of Graphene-Family Nanomaterials: an Update